查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012367

生物可吸收支架市場：2026-2032年全球市場預測（按材料、產品類型、分解時間、應用、最終用戶和分銷管道分類）

Bioabsorbable Stents Market by Material, Product Type, Degradation Time, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物可吸收支架市場價值將達到 6.0756 億美元，到 2026 年將成長至 6.4565 億美元，到 2032 年將達到 9.5271 億美元，複合年成長率為 6.63%。

主要市場統計數據
基準年 2025 6.0756億美元
預計年份：2026年 6.4565億美元
預測年份 2032 9.5271億美元
複合年成長率 (%) 6.63%

生物可吸收支架創新的潛力與未來前景：推動介入心臟病學，實現下一代患者照護。

生物可吸收支架領域正成為介入心臟病學領域的變革性尖端技術，可望解決永久性金屬植入長期存在的難題。與長期留在動脈壁內的傳統支架不同，生物可吸收支架會逐漸分解，使患者無需長期承受體內異物，即可恢復血管功能。這一轉變標誌著介入性心臟病學領域的模式轉移，重新定義了成功的衡量標準，從單純的血管通暢率轉向恢復血管舒縮功能和最大限度減少遠期併發症。

突破性的進步和顛覆性的技術，重新定義了生物可吸收支架的開發和臨床應用前景。

材料科學的進步已將生物可吸收支架從概念原型轉變為具有商業性可行性的產品。從早期的聚合物基質到新一代金屬合金的轉變，提高了徑向剛度，並實現了對吸收動力學的更好控制。同時，新型表面處理和藥物釋放型塗層解決了新生內膜增生這一長期難題，將臨時機械支撐與局部藥物治療的優勢相結合。

分析2025年美國新關稅對生物可吸收支架供應鏈和市場動態的廣泛影響。

2025年初，美國對鎂和特殊聚合物等關鍵原料加徵關稅，對全球供應鏈產生了連鎖反應。進口關稅推高了關鍵合金和單體的單價，立即給製造商帶來壓力。儘管這些關稅旨在保護國內生產，但卻意外地促使企業迅速重新評估籌資策略和原料採購模式。

透過按材料成分、產品類型、分解時間、臨床應用和最終用戶對生物可吸收支架進行分類，可以獲得關鍵見解。

材料成分的差異已成為支架性能的決定性因素，金屬和聚合物兩大類構成了產品系列。在金屬產品系列中，工程師利用鐵基來確保可控的徑向強度和可預測的耐腐蝕性能，而鎂合金系統則可實現加速吸收和最大限度減少發炎反應。鋅合金則提供了一種折衷方案，兼具可控的使用壽命和機械柔軟性。在聚合物支架設計中，聚左旋乳酸）支架已成為公認的標竿。聚己內酯（PCL）、聚二氧雜環己酮（氧環己酮聚合體）和聚乙醇酸）的同步創新提供了不同的分解週期和動態性能，可根據特定的病變形態進行客製化。

探索美洲、歐洲、中東和非洲以及亞太地區採用生物可吸收支架的獨特區域趨勢和成長要素。

在美洲，完善的臨床基礎設施和優惠的報銷機制正在加速生物可吸收支架技術的早期應用。美國仍然是創新和臨床試驗的主要中心，而由於心血管疾病盛行率的上升和醫療服務可近性的改善，一些拉丁美洲市場對該技術的興趣也日益濃厚。前沿研究和不斷擴大的患者群體這雙重動力進一步提升了該地區的戰略重要性。

揭示推動生物可吸收支架製造商發展的關鍵競爭策略、研發合作夥伴關係和創新產品平臺。

領先的醫療設備研發公司正在加大對特種合金的研究力度，並投資下一代聚合物工程。跨國支架製造商與先進材料公司之間的合作，促成了獨特配方的開發，這些配方既能最佳化徑向支撐，又能控制分解速率。同時，越來越多的公司正與學術機構達成合作協議，透過體外試驗和動物模型檢驗新型支架平台。

透過策略創新，為產業領導者提供可操作的藍圖，以加速生物可吸收支架的商業性成功和臨床應用。

為了充分利用不斷變化的臨床和監管環境，行業相關人員應優先發展先進材料研發項目，以平衡機械完整性和可預測的生物利用度。策略性地專注於下一代合金和聚合物連接劑，將有助於產品差異化，並解決性能權衡這一長期存在的難題。

調查方法的詳細內容包括專家訪談、二手資料以及定性和定量分析：提供高度可靠的見解。

我們的分析利用對介入性心臟病專家、材料科學家和供應鏈高管的深入訪談，以獲取關於生物可吸收支架的真實世界觀點。除了這些主要訪談之外，我們還對監管文件、臨床試驗註冊資訊、專利申請和同行評審文獻進行了詳細審查。

本報告整合了關鍵發現和策略挑戰，以確定生物可吸收支架在創新、臨床部署和市場成熟方面的未來路徑。

生物可吸收支架的發展歷程體現了材料技術創新、血管修復治療的臨床需求以及產業內部策略合作的整合。金屬和聚合物科學的進步提升了支架的性能，而精湛的製造程序則實現了精確的形狀設計，並可根據特定需求定製藥物釋放型功能。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生物可吸收支架市場：依材料分類

  • 金屬基生物可吸收支架
    • 鐵基
    • 鎂基
    • 鋅合金
  • 以聚合物為基礎的生物可吸收支架
    • 聚左旋乳酸（PLLA）
    • 聚己內酯（PCL）
    • 氧環己酮聚合體（PDO）
    • 聚乙醇酸（PGA）

第9章：生物可吸收支架市場：依產品類型分類

  • 藥物釋放型型
  • 非藥物釋放型型

第10章：生物可吸收支架市場依時期細分

  • 12-24個月
  • 12個月以下
  • 超過24個月

第11章：生物可吸收支架市場：依應用領域分類

  • 冠狀動脈疾病（CAD）
  • 神經血管疾病
  • 適合兒童
  • 周邊動脈疾病（PAD）

第12章：生物可吸收支架市場：依最終用戶分類

  • 學術和研究機構
  • 門診手術中心
  • 心臟中心
  • 醫院

第13章：生物可吸收支架市場：依通路分類

  • 離線
  • 線上

第14章：生物可吸收支架市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：生物可吸收支架市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：生物可吸收支架市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國生物可吸收支架市場

第18章：中國生物可吸收支架市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Arterius Ltd
  • B. Braun SE
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • ELLA-CS, sro
  • JW Medical Systems Ltd. Biosensors International Group, Ltd.
  • Kaneka Corporation
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences
  • Microport Scientific Corporation
  • OrbusNeich Medical Group Holdings Limited
  • Q3 Medical Group
  • Reva Medical
  • SafeGuard Surgical, Inc.
  • Shandong Hua'an Biotechnology
  • Sino Medical Sciences Technology Inc.
  • Svelte Medical Systems Inc
  • Terumo Corporation
  • WEGO HEALTHCARE（SHENZHEN）CO., LTD
  • Zorion Medical Inc.
Product Code: MRR-4311778F8FFC

The Bioabsorbable Stents Market was valued at USD 607.56 million in 2025 and is projected to grow to USD 645.65 million in 2026, with a CAGR of 6.63%, reaching USD 952.71 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 607.56 million
Estimated Year [2026] USD 645.65 million
Forecast Year [2032] USD 952.71 million
CAGR (%) 6.63%

Uncovering the Promise and Potential of Bioabsorbable Stent Innovations Driving Cardiovascular Intervention Toward Next-Generation Patient Care

The field of bioabsorbable stents has emerged as a transformative frontier within cardiovascular intervention, promising to resolve long-standing limitations of permanent metallic implants. Unlike traditional stents that remain lodged within the arterial wall, bioabsorbable designs enable gradual degradation, offering patients the prospect of restored vessel function without long-term foreign body presence. This transition represents a paradigm shift in interventional cardiology, redefining success metrics from mere patency rates to the restoration of natural vasomotion and minimized late-stage complications.

Historically, the adoption of bioabsorbable scaffold technology has been tempered by material challenges, including mechanical strength, controlled degradation, and biocompatibility. However, continuous improvements in alloy processing, polymer chemistry, and analytical imaging have unlocked renewed confidence among clinicians and device makers. Today's research landscape is characterized by interdisciplinary collaborations that refine scaffold architecture down to the microscopic level, ensuring reliable radial support through the critical healing window before resorption commences.

This executive summary distills key observations from recent clinical outcomes, supply chain analyses, and competitive positioning. By tracing the evolution of scaffold design, evaluating emerging regulatory dynamics, and highlighting pivotal industry maneuvers, this introduction sets the stage for an in-depth exploration of the factors shaping the next generation of bioabsorbable stents.

Revolutionary Advances and Disruptive Technologies Redefining the Landscape of Bioabsorbable Stent Development and Clinical Implementation

Advances in material science have propelled bioabsorbable stents from conceptual prototypes to commercially viable options. The transition from early polymer matrices to next-generation metal alloys has enhanced radial force and controlled resorption kinetics. At the same time, novel surface treatments and drug-eluting coatings have addressed the perennial challenge of neointimal hyperplasia, marrying the benefits of transient mechanical support with localized pharmacotherapy.

Manufacturing innovations have also played a critical role in redefining the landscape. Precision laser cutting and additive manufacturing techniques enable intricate scaffold geometries that optimize fluid dynamics and endothelialization. Concurrently, bioresorbable polymer blends now incorporate specialized linkers that modulate degradation rates, ensuring structural integrity throughout the vascular remodeling phase.

Clinically, these technological advances have intersected with enhanced procedural guidance systems. High-definition intravascular imaging and computational fluid modeling facilitate personalized stent selection and deployment, reducing the incidence of malapposition and scaffold recoil. Collectively, these transformative shifts mark a new era in which bioabsorbable stents no longer represent an aspirational concept but a practical therapeutic option under broader clinical consideration.

Analyzing the Far-Reaching Consequences of Newly Imposed United States Tariffs on Bioabsorbable Stent Supply Chains and Market Dynamics in 2025

Early in 2025 the introduction of new United States tariffs on key raw materials including magnesium and specialty polymers reverberated across global supply chains. Manufacturers faced immediate cost pressures as import duties raised the unit cost of critical alloys and monomers. Although these levies aimed to protect domestic production, they inadvertently fueled a rapid reassessment of sourcing strategies and material procurement models.

As tariffs took effect, device developers evaluated the cumulative impact on production economics and pricing models. The heightened input costs necessitated a shift toward localized alloy fabrication and intensified collaboration with domestic polymer suppliers. In some cases, organizations accelerated long-term commitments with regional foundries to secure favorable pricing and reduce exposure to import duty fluctuations.

Moreover, these policy changes spurred a wave of strategic integration. Several stent providers began exploring in-house polymer synthesis capabilities and joint ventures with alloy foundries. Such vertical alignment not only offset regulatory cost burdens but also enabled tighter control over material specifications and quality assurance. Ultimately the evolving tariff environment affirmed the critical importance of supply chain resilience in sustaining bioabsorbable stent innovation.

Illuminating Critical Insights from Segmenting Bioabsorbable Stents by Material Composition Product Type Degradation Time Clinical Application and End User

Distinct material compositions have emerged as defining factors in scaffold performance, with metal-based and polymer-based categories shaping product portfolios. In the metal-based cohort engineers leverage iron-based alloys for managed radial strength and predictable corrosion profiles while magnesium-based systems deliver accelerated resorption and minimal inflammation. Zinc-based blends strike an intermediate balance, offering controlled service life and mechanical flexibility. For polymer-based designs, poly-L-lactic acid scaffolds represent the established benchmark. Concurrent innovations in polycaprolactone, polydioxanone, and polyglycolic acid provide varied degradation windows and tailored biomechanical properties for specialized lesion morphologies.

Beyond material differentiation, the distinction between drug-eluting and non-drug-eluting stents continues to influence clinical utility. Drug-eluting variants incorporate antiproliferative agents that mitigate neointimal hyperplasia, improving long-term vessel patency. Non-drug-eluting scaffolds offer simplicity and cost advantages in low-risk patients or small-vessel applications where minimal pharmacotherapy suffices.

Degradation kinetics also inform product positioning. Scaffolds engineered to dissolve within less than twelve months accommodate rapid vessel healing, while options designed for twelve to twenty-four months support more complex lesions requiring extended scaffolding. Systems with resorption profiles exceeding two years maintain mechanical integrity for protracted intervals, addressing chronic occlusions and high-stress vascular segments.

Clinical applications span from coronary artery disease management to neurovascular interventions, pediatric congenital anomalies, and peripheral arterial disease treatments. This breadth underscores the technology's versatility but also demands tailored scaffold characteristics for each anatomical context.

Diverse end-user settings further shape adoption patterns. Academic and research institutions drive early-phase evaluations and protocol development, ambulatory surgical centers optimize procedural efficiency, high-volume cardiac centers focus on outcome standardization, and hospitals integrate bioabsorbable scaffolds into multidisciplinary care pathways.

Finally the distribution landscape continues to evolve, with traditional hospital procurement complemented by emerging digital platforms that streamline access and support remote training. This dual-channel model enhances reach while preserving critical in-person service and education components.

Exploring Distinct Regional Dynamics and Growth Drivers Shaping Adoption of Bioabsorbable Stents Across Americas Europe Middle East Africa and Asia Pacific

In the Americas, robust clinical infrastructure and favorable reimbursement frameworks have fostered early uptake of bioabsorbable scaffold technology. The United States remains the primary innovation and trial hub, while select Latin American markets demonstrate growing interest fueled by rising cardiovascular disease prevalence and improving healthcare access. This dual dynamic of high-end research and expanding patient outreach reinforces the region's strategic importance.

Europe, the Middle East, and Africa exhibit considerable heterogeneity shaped by diverse regulatory regimes and health technology assessment processes. Western European nations combine rigorous clinical evidence requirements with streamlined European Union pathways, creating a balanced environment for scaffold introduction. Conversely, markets in the Gulf Cooperation Council and sub-Saharan Africa reflect uneven adoption driven by infrastructure variability and prioritization of acute care spending. Nevertheless, regional initiatives to bolster cardiovascular services and collaborative procurement consortia are gradually nurturing a more receptive ecosystem.

Asia-Pacific stands out for its unparalleled patient volumes and rapid hospital modernization efforts. In China and India, government incentives for indigenously developed medical technologies have accelerated local polymer and alloy development. Japan and South Korea complement this momentum with strong clinical trial infrastructure and regulatory alignment to global standards. Across Southeast Asia and Oceania, growing disease burden and expanding cardiac intervention programs signal an expanding addressable base for bioabsorbable stent solutions.

Unveiling the Leading Competitive Strategies R&D Collaborations and Innovative Product Pipelines Driving Bioabsorbable Stent Manufacturers Forward

Leading device developers are intensifying investments in specialized alloy research and next-generation polymer engineering. Partnerships between multinational stent manufacturers and advanced materials firms have yielded proprietary formulations that optimize radial support while controlling degradation rates. Concurrently, a growing number of companies are inking collaborative agreements with academic institutions to validate new scaffold platforms in bench and animal models.

Recent consortiums and research alliances have also accelerated the integration of drug-release technologies. By combining expertise in pharmacology, polymer science, and surface fabrication, these partnerships aim to extend the therapeutic window of antiproliferative medications and enhance endothelial recovery. Such collective endeavors reflect a trend toward shared innovation ecosystems rather than isolated R&D silos.

Beyond laboratory alliances, a series of mergers and acquisitions have reshaped competitive trajectories. Established cardiovascular device firms have acquired startups with differentiated bioresorbable offerings to augment their product suites and accelerate clinical market entry. These consolidation moves underscore the sector's emphasis on scale, regulatory expertise, and comprehensive distribution capabilities.

Additionally, several leading stent providers have inaugurated innovation funds and incubators dedicated to early-stage scaffold concepts. By nurturing startup ecosystems and providing co-development resources, they aim to replenish their pipelines with disruptive ideas and retain first-mover advantages.

Empowering Industry Leaders with Actionable Roadmaps to Accelerate Commercial Success and Clinical Adoption of Bioabsorbable Stents Through Strategic Innovation

To capitalize on evolving clinical and regulatory landscapes, industry participants should prioritize advanced material development programs that balance mechanical integrity with predictable bioresorption. Strategic focus on next-generation alloys and polymer linkers will differentiate offerings and address persistent performance trade-offs.

Stakeholders must also bolster supply chain resilience by diversifying vendor relationships and exploring regional manufacturing hubs for critical feedstocks. Vertical integration models and long-term offtake agreements can mitigate the impact of tariff fluctuations and ensure uninterrupted production capacity.

Engaging closely with key opinion leaders and trial institutions will be essential for building compelling clinical evidence. Early demonstration of favorable safety and efficacy profiles through investigator-initiated studies can streamline regulatory interactions and strengthen reimbursement dossiers.

Finally, expanding digital distribution channels alongside traditional hospital networks will enhance reach and facilitate remote training programs. Innovative e-platforms that combine product ordering with interactive physician education will support adoption in both mature and emerging markets.

Detailing a Research Methodology That Combines Expert Interviews Secondary Data and Qualitative Quantitative Analysis to Deliver Insight Credibility

Our analysis draws on in-depth interviews with interventional cardiologists, materials scientists, and supply chain executives to capture real-world perspectives on bioabsorbable stents. These primary conversations were complemented by detailed reviews of regulatory documents, clinical trial registries, patent filings, and peer-reviewed literature.

Secondary research encompassed government healthcare reports, industry white papers, and conference proceedings to ensure an extensive contextual foundation. Data from cardiology societies and professional associations provided additional validation of procedural volumes and clinical preferences.

Qualitative insights were systematically translated into quantitative metrics through structured expert panels and weighted scoring models. This combined approach enabled robust cross-validation of findings and identification of high-impact trends.

Throughout the research process, methodological rigor was maintained via peer review and iterative feedback loops with domain specialists. Quality assurance protocols ensured that all data sources met predefined reliability and relevance criteria.

Synthesizing Key Findings and Strategic Imperatives to Illuminate the Path Forward for Bioabsorbable Stent Innovation Clinical Adoption and Market Maturation

The evolution of bioabsorbable stents reflects a convergence of material innovations, clinical demand for restorative vessel therapies, and strategic industry collaboration. Advances in metal and polymer science have enhanced scaffold performance, while refinements in manufacturing enable precise geometries and tailored drug-eluting capabilities.

Segment-specific insights reveal that performance profiles vary widely across material types, degradation windows, clinical indications, end-user settings, and distribution pathways. Regional analyses highlight distinct adoption patterns in the Americas, Europe Middle East & Africa, and Asia-Pacific, each driven by local healthcare infrastructure, regulatory priorities, and reimbursement models.

Competitive dynamics center on strategic partnerships, R&D alliances, and targeted acquisitions that expand pipelines and accelerate time-to-market. To sustain momentum, industry leaders must invest in resilient supply chains, cultivate clinical evidence, and embrace digital engagement strategies.

Taken together these findings illuminate a clear strategic path for organizations seeking to lead in the bioabsorbable stent arena. Executing on these imperatives will drive both near-term impact and long-term growth as the field advances toward standard of care adoption and broader patient benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioabsorbable Stents Market, by Material

  • 8.1. Metal-based Bioabsorbable Stents
    • 8.1.1. Iron-based
    • 8.1.2. Magnesium-based
    • 8.1.3. Zinc-based Alloys
  • 8.2. Polymer-based Bioabsorbable Stents
    • 8.2.1. Poly-L-lactic acid (PLLA)
    • 8.2.2. Polycaprolactone (PCL)
    • 8.2.3. Polydioxanone (PDO)
    • 8.2.4. Polyglycolic acid (PGA)

9. Bioabsorbable Stents Market, by Product Type

  • 9.1. Drug-Eluting
  • 9.2. Non-Drug-Eluting

10. Bioabsorbable Stents Market, by Degradation Time

  • 10.1. 12-24 months
  • 10.2. Less than 12 months
  • 10.3. More 24 months

11. Bioabsorbable Stents Market, by Application

  • 11.1. Coronary Artery Disease (CAD)
  • 11.2. Neurovascular Disease
  • 11.3. Pediatric Applications
  • 11.4. Peripheral Artery Disease (PAD)

12. Bioabsorbable Stents Market, by End User

  • 12.1. Academic & Research Institutions
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Cardiac Centers
  • 12.4. Hospitals

13. Bioabsorbable Stents Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Bioabsorbable Stents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Bioabsorbable Stents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Bioabsorbable Stents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Bioabsorbable Stents Market

18. China Bioabsorbable Stents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Arterius Ltd
  • 19.7. B. Braun SE
  • 19.8. BIOTRONIK SE & Co. KG
  • 19.9. Boston Scientific Corporation
  • 19.10. Cardionovum GmbH
  • 19.11. Elixir Medical Corporation
  • 19.12. ELLA - CS, s.r.o.
  • 19.13. JW Medical Systems Ltd. Biosensors International Group, Ltd.
  • 19.14. Kaneka Corporation
  • 19.15. Kyoto Medical Planning Co. Ltd.
  • 19.16. Lepu Medical Technology Co. Ltd.
  • 19.17. Meril Life Sciences
  • 19.18. Microport Scientific Corporation
  • 19.19. OrbusNeich Medical Group Holdings Limited
  • 19.20. Q3 Medical Group
  • 19.21. Reva Medical
  • 19.22. SafeGuard Surgical, Inc.
  • 19.23. Shandong Hua'an Biotechnology
  • 19.24. Sino Medical Sciences Technology Inc.
  • 19.25. Svelte Medical Systems Inc
  • 19.26. Terumo Corporation
  • 19.27. WEGO HEALTHCARE (SHENZHEN) CO., LTD
  • 19.28. Zorion Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOABSORBABLE STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOABSORBABLE STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY IRON-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY IRON-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY IRON-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ZINC-BASED ALLOYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ZINC-BASED ALLOYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ZINC-BASED ALLOYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYDIOXANONE (PDO), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYDIOXANONE (PDO), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYDIOXANONE (PDO), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DRUG-ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DRUG-ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DRUG-ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NON-DRUG-ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NON-DRUG-ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NON-DRUG-ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY 12-24 MONTHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY 12-24 MONTHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY 12-24 MONTHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY LESS THAN 12 MONTHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY LESS THAN 12 MONTHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY LESS THAN 12 MONTHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MORE 24 MONTHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MORE 24 MONTHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MORE 24 MONTHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE (CAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE (CAD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE (CAD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NEUROVASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NEUROVASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NEUROVASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PEDIATRIC APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PEDIATRIC APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PEDIATRIC APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. G7 BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 195. G7 BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 196. G7 BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NATO BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. NATO BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 204. NATO BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 205. NATO BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)